Carter D. Brooks

Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP)

David T. Purtilo, Kiyoshi Sakamoto, Vanessa M. Barnabei et al. · The American Journal of Medicine · 1982 · 185 citations

Lymphoid Neoplasia, Epstein-barr Virus-induced Diseases, Immunology +4

Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects

Robert Cass, Carter D. Brooks, N. Havrilla et al. · Antimicrobial Agents and Chemotherapy · 2011 · 68 citations · Full text

Drug Safety, Steady State, Healthy Subjects +11

Sulfasalazine for the management of juvenile rheumatoid arthritis.

Carter D. Brooks · PubMed · 2001 · 55 citations

Tolerance and pharmacology of ibuprofen.

Carter D. Brooks, Carl A. Schlagel, N Chandra Sekhar et al. · PubMed · 1973 · 51 citations

Molecular Pharmacology, Pharmacological Study, Pain Medicine +4

Preparation of (R)-(+)-N-[3-[5-[(4-Fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitor.

Carter D. Brooks, Andrew O. Stewart, James D. Ratajczyk et al. · Journal of Medicinal Chemistry · 1995 · 44 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Aldehyde Dehydrogenase +15